| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Commercial Officer | Chief Commercial Officer | SVP Sales &Commercial Ops
1 company
Cheng Sohanya Roshan is an EVP &Chief Commercial Officer at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $704K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2025 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Commercial Officer | Sell | 325 | $6.43 | $2,089.75 | -0.9% | +7.2% | - | |
| Mar 4, 2025 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Commercial Officer | Sell | 3,445 | $6.29 | $21,669.05 | -9.1% | -35.3% | +43.1% | |
| Sep 4, 2024 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Commercial Officer | Sell | 5,356 | $0.72 | $3,865.96 | -1.3% | +13.7% | -37.0% | |
| Mar 1, 2024 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Commercial Officer | Sell | 26,949 | $1.18 | $31,683.60 | -3.3% | -20.0% | -55.3% | |
| Sep 1, 2023 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Commercial Officer | Sell | 7,415 | $1.33 | $9,871.59 | -3.5% | -43.4% | -44.1% | |
| Jun 8, 2023 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Commercial Officer | Sell | 1,839 | $2.35 | $4,321.65 | -0.9% | -50.0% | -59.0% | |
| Mar 1, 2023 | KPTI Karyopharm Therapeutics Inc. | EVP &Chief Commercial Officer | Sell | 11,239 | $3.03 | $34,045.18 | -5.1% | -28.2% | -62.5% | |
| Jun 13, 2022 | KPTI Karyopharm Therapeutics Inc. | Chief Commercial Officer | Sell | 1,551 | $5.21 | $8,074.77 | -0.8% | +9.5% | -56.7% |